Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Novartis hails longer-lasting COPD drug

September 20, 2010 Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler

A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …
News
GlaxoSmitKline logo

GSK workers in Ireland await review

September 20, 2010 Manufacturing and Production, Research and Development GlaxoSmithKline, Ireland, job cuts

Workers at a GlaxoSmithKline facility in Ireland are anxiously awaiting the outcome of an official review of the operation amid …
News

Contract research news in brief

September 20, 2010 Research and Development Covance, Galapagos, MediData Solutions, MediSync BioServices, PPD, Quotient Bioresearch, i3

A round-up of recent news from the CRO sector, featuring updates from Covance, Quotient Bioresearch, PPD, i3, Galapagos, MediSync BioServices …
News
Alan_Watt

Cellzome hires GSK’s Alan Watt

September 20, 2010 Research and Development Cellzome, appointment, research and development

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president …
Appointment

GSK switches to subcutaneous route for antibody

September 16, 2010 Research and Development Arzerra, Genmab, GlaxoSmithKline, ofatumumab

GlaxoSmithKline says it will switch development of a new antibody treatment to a subcutaneous injection, to make it more commercially …
News

Norgine appoints global quality director

September 16, 2010 Manufacturing and Production, Research and Development Norgine, appointment, manufacturing and production, research and development

Rosemarie Corrigan has joined European specialty pharmaceutical company Norgine as director of global quality, taking a leadership role across a …
Appointment

Gene therapy advance hailed for thalassemia

September 16, 2010 Research and Development Bluebird Bio, gene therapy, thalassemia

A new gene therapy for one of the most frequently inherited genetic disorders has produced promising results. The trial by …
News

Novo expands diabetes research in China

September 16, 2010 Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
News

Pepscan and Tibotec sign peptides deal

September 15, 2010 Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
News

Positive results for irritable bowel syndrome drug

September 14, 2010 Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
News

Future of Roche diabetes trial uncertain

September 14, 2010 Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …
News

Genzyme planning 1,000 job cuts

September 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
News

Zactima extends progression free survival in other thyroid cancers

September 13, 2010 Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
News

AZ signs cancer development deal

September 13, 2010 Research and Development AstraZeneca, CRT, Cancer Research UK

AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
News

Transgene acquires rights to cancer vaccine

September 10, 2010 Research and Development JX-594, Jennerex, Transgene, cancer vaccine

French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026